STOCK TITAN

Orasure Tech SEC Filings

OSUR NASDAQ

Welcome to our dedicated page for Orasure Tech SEC filings (Ticker: OSUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Parsing OraSure Technologies’ regulatory paperwork can feel like sifting through lab samples—essential details are spread across hundreds of pages and dense FDA terminology. Whether you’re hunting for diagnostic-segment margins or tracking when executives trade shares, the disclosures are easy to miss. This page gathers every document the moment it hits EDGAR, delivering OraSure Technologies SEC filings explained simply.

Our AI engine reads the filings side-by-side with you, turning a 250-page OraSure Technologies annual report 10-K simplified into a two-minute brief, flagging revenue shifts driven by oral-fluid HIV tests and molecular collection kits. Need the next OraSure Technologies quarterly earnings report 10-Q filing? It appears here with instant OraSure Technologies earnings report filing analysis, plus red-lined changes from prior quarters. Real-time alerts highlight OraSure Technologies insider trading Form 4 transactions, so you can see OraSure Technologies Form 4 insider transactions real-time without refreshing the page.

Use the menu to jump straight to OraSure Technologies 8-K material events explained, the latest OraSure Technologies proxy statement executive compensation tables, or in-depth notes on FDA clearances embedded in footnotes. Our AI summaries clarify why a supply-chain disclosure matters, and a comparison tool helps professionals understand molecular solutions revenue trends quarter over quarter. Still unsure? A one-click guide for understanding OraSure Technologies SEC documents with AI answers common questions and points you to OraSure Technologies executive stock transactions Form 4 for context. Spend less time reading, more time deciding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Orasure Tech (OSUR)?

The current stock price of Orasure Tech (OSUR) is $3.01 as of June 27, 2025.

What is the market cap of Orasure Tech (OSUR)?

The market cap of Orasure Tech (OSUR) is approximately 224.4M.

What primary products does OraSure Technologies manufacture?

OraSure Technologies specializes in rapid diagnostic tests, oral fluid collection devices, molecular testing kits, and cryosurgical products. These products are used for detecting infectious diseases, drug testing, and sample management.

How does the diagnostics segment contribute to the company's business?

The diagnostics segment focuses on oral fluid-based testing, offering rapid and non-invasive tests for conditions like HIV and HCV, as well as tests for drugs of abuse. This segment emphasizes accuracy, ease of use, and early detection in healthcare settings.

What role does molecular testing play in OraSure's product portfolio?

The molecular solutions segment develops kits for collecting, stabilizing, and transporting genetic material, which are essential for both hereditary and infectious disease testing. This area is a significant revenue driver and is critical for clinical laboratories and public health establishments.

In which markets does OraSure Technologies operate?

OraSure Technologies serves a diverse range of markets including clinical laboratories, hospitals, physician offices, research institutions, public health organizations, and direct-to-consumer channels across the United States and internationally.

How does OraSure ensure the quality of its diagnostic tests?

The company adheres to stringent regulatory standards and comprehensive quality assurance processes. Its tests undergo rigorous clinical evaluations to ensure they provide accurate, reliable results for healthcare providers and patients alike.

What competitive advantages does OraSure hold in the diagnostics industry?

OraSure combines technical expertise in oral fluid diagnostics with a robust portfolio of molecular testing solutions. Its focus on non-invasive testing methods and high standards of product quality sets it apart in the competitive healthcare diagnostics landscape.

What are the key regulatory considerations for OraSure's products?

OraSure's products meet strict regulatory requirements in all markets, undergoing extensive testing and validation to comply with healthcare standards. The company maintains a strong focus on quality control and regulatory compliance to ensure the safety and efficacy of its devices.

How does OraSure support various healthcare sectors?

OraSure supplies a wide range of diagnostic and sample management solutions to institutions including clinical laboratories, hospitals, and research centers. This comprehensive approach helps improve healthcare delivery, patient outcomes, and public health initiatives.
Orasure Tech

NASDAQ:OSUR

OSUR Rankings

OSUR Stock Data

224.40M
71.04M
4.07%
91.51%
3.28%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BETHLEHEM